Pricing

Travere Therapeutics Inc (TVTX)

followers ·
Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Eric M. Dube
Employees:
460
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
888-969-7879
    Formally known as:
  • DESERT GATEWAY INC
  • DESERT GATEWAY, INC.
  • DESERT GATEWAY, INC. COMMON STOCK
  • DESERT GATEWAY, INC. COMMON STOCK
Travere Therapeutics, Inc. focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid. The company's product candidates also consist of Sparsentan, which is in Phase III clinical trial for the. treatment of focal segmental glomerulosclerosis and immunoglobulin A nephropathy.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available